Source: Eur Respir J, 50 (4) 1701725; 10.1183/13993003.01725-2017
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Robert P. Baughman, Oksana A. Shlobin. Treatment of sarcoidosis-associated pulmonary hypertension: so close, and yet so far. Eur Respir J, 50 (4) 1701725; 10.1183/13993003.01725-2017

Member's Comments

No comment yet.

Related content which might interest you: Diagnosis and treatment of pulmonary hypertension in COPD patients: how far should we go? Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019 Newly diagnosed patients with chronic thromboembolic pulmonary hypertension and PASP<50 mmHg. Do they need pulmonary endarterectomy? Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 Pulmonary hypertension Source: Eur Respir Rev 2013; 22: 20-25 Year: 2013 Treatment of pulmonary hypertension Source: Virtual Congress 2020 – Treatment in pulmonary hypertension Year: 2020 Update on current treatment options of pulmonary hypertension Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine Year: 2006 Long-term outcome of sarcoidosis-associated pulmonary hypertension in the modern treatment era Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 Is survival in patients with severe group 3 pulmonary hypertension influenced by targeted therapy? Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Conclusion: treatment of pulmonary hypertension in COPD patients Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange Year: 2005 Which patients are SaPHe in sarcoidosis-associated pulmonary hypertension? Source: Eur Respir J, 55 (5) 2000700; 10.1183/13993003.00700-2020 Year: 2020 Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registry Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 Challenging cases in PH Source: Eur Respir Rev 2008; 17: 19-23 Year: 2007 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 The effect of treatment on right ventriculo-arterial coupling in idiopathic pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics Source: Eur Respir J 2005; 25: 783-788 Year: 2005 Observational retrospective study on the treatment of pulmonary hypertension (PH) associated to pulmonary disease in patient with PH out of proportion Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 ERS statement on chronic thromboembolic pulmonary hypertension Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension Year: 2021 Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016